Targeting the JAK/STAT pathway with isoliquiritigenin in ovarian cancer: molecular mechanisms and therapeutic implications

Ovarian cancer, one of the most common gynecological malignancies, ranks as the fifth leading cause of cancer death in women. To investigate the mechanism by which isoliquiritigenin (ISL) regulates the JAK/STAT signaling pathway in ovarian cancer intervention, this review integrates cellular, animal...

Olles dieđut

Bibliográfalaš dieđut

Váldodahkkit:	Meidan Ding, Fangfang Guo, Ping Lin
Materiálatiipa:	Artigo
Giella:	Inglês
Almmustuhtton:	Frontiers Media S.A. 2026-06-01
Ráidu:	Frontiers in Pharmacology
Fáttát:	isoliquiritigenin JAK/STAT signaling pathway molecular mechanisms ovarian cancer therapeutic potential tumor immune microenvironment
Liŋkkat:	https://www.frontiersin.org/articles/10.3389/fphar.2026.1828829/full
Fáddágilkorat:	Lasit fáddágilkoriid Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!